Ludwig Cancer Research cut a $90 million check to the Stanford University School of Medicine, the school announced Jan. 6.
The grant will support the school's work in cancer stem cells, which may drive the growth of some cancers, according to Stanford.
The grant brings Ludwig Cancer Research's total contribution to the center to $150 million, according to Stanford. It complements Stanford's Cancer Initiative, a $250 million campaign to advance research and improve patient care.
Stanford is one of six institutions that received grants from the New York-based cancer research fund. The combined total of the six grants is $540 million. Johns Hopkins University, Harvard University, the Massachusetts Institute of Technology, Memorial Sloan-Kettering Cancer Center and the University of Chicago also received grants.
Stanford will use the money to support the endowment of its Ludwig Center for Cancer Stem Cell Research and Medicine at Stanford.
"Ludwig funded cancer stem-cell research at a time when it was unpopular and disbelieved," said Irving Weissman, the center's director. "Its support has enabled us to take a discovery that was first made in leukemia and apply it to all cancers and to develop new immunotherapies to targets revealed in these cancer stem cells."
The Ludwig Cancer Research fund was established in 1971 by billionaire businessman Daniel Ludwig, who died in 1992.